Dudum Amends Hims & Hers 13D Filing

TL;DR

Andrew Dudum updated his Hims & Hers stake filing on 10/25/24, event date 03/01/24.

AI Summary

Andrew Dudum filed an amendment (No. 2) to his Schedule 13D on October 25, 2024, regarding his holdings in Hims & Hers Health, Inc. The filing indicates a change in the date of the event requiring this statement to March 1, 2024. Dudum's address is listed as 2269 Chestnut Street, #523, San Francisco, CA.

Why It Matters

This amendment updates the filing for significant beneficial ownership of Hims & Hers Health, Inc., providing transparency to investors about changes in holdings.

Risk Assessment

Risk Level: low — This is a routine amendment to a Schedule 13D filing, not indicating new material events or significant shifts in ownership.

Key Numbers

• 2 — Amendment Number (Indicates this is the second amendment to the original filing.)

Key Players & Entities

• Andrew Dudum (person) — Filing person and beneficial owner
• Hims & Hers Health, Inc. (company) — Subject company
• Oaktree Acquisition Corp. (company) — Former company name

FAQ

Key Financial Figures

• $0.0001 — Name of Issuer) Class A Common Stock, $0.0001 par value (Title of Class of Securiti

Filing Documents

• d898514dsc13da.htm (SC 13D/A) — 63KB
• d898514dex991.htm (EX-99.1) — 4KB
• 0001193125-24-244170.txt ( ) — 68KB

is hereby amended and restated in its entirety as follows

Item 5 is hereby amended and restated in its entirety as follows: The information contained in Item 3 and 4 of this Schedule 13D is incorporated by reference herein. (a, b) The responses of the Reporting Person with respect to Rows 7 through 13 of the cover page to this Amendment No. 2 are incorporated herein by reference. (c) The transactions in the securities of the Issuer by the Reporting Person since the sixtieth day prior to the date of the event requiring the filing of this Amendment No. 2 are set forth in Schedule A hereto and are incorporated herein by reference. (d) To the best knowledge of the Reporting Person, no person other than the Reporting Person or his affiliated trusts has the right to receive, or the power to direct the receipt of, dividends from, or the proceeds from the sale of the shares of Class A Common Stock reported herein. (e) Not applicable.

Material to be

Item 7. Material to be Filed as Exhibits. Exhibit 99.1: Duly authorized under Power of Attorney by and on behalf of Andrew Dudum. CUSIP No. 433000 106 Page 3 of 3 SIGNATURE After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct. Andrew Dudum By: /s/Alexandra Cotter Wilkins, as Attorney-in-Fact for Andrew Dudum Date: October 25, 2024 Schedule A Open-Market Sales Pursuant to Rule 10b5-1 Trading Plan Transaction Date Shares of Class A Common Stock Sold 1 Weighted-Average Sale Price per Share Aggregate Sale Value 01/25/24 127,688 $ 9.0795 $ 1,159,343.20 01/26/24 52,940 $ 9.1068 $ 482,113.99 01/29/24 15,100 $ 9.0082 $ 136,023.82 02/12/24 81,541 $ 9.9832 $ 814,040.11 02/13/24 97,208 $ 9.5775 $ 931,009.62 02/14/24 77,382 $ 9.9024 $ 766,267.52 02/29/24 577,007 $ 12.9639 $ 7,480,261.05 03/01/24 188,896 $ 13.0706 $ 2,468,984.06 03/01/24 51,653 * $ 13.0706 $ 675,135.70 03/01/24 144,448 * $ 13.0706 $ 1,888,022.03 03/20/24 50,361 * $ 16.3431 $ 823,054.86 04/04/24 93,521 $ 14.9575 $ 1,398,840.36 04/04/24 923 $ 15.6323 $ 14,428.61 04/04/24 93,434 $ 14.9733 $ 1,399,015.31 04/04/24 1,010 $ 15.6341 $ 15,790.44 04/04/24 128,546 * $ 14.7031 $ 1,890,024.69 04/04/24 15,898 * $ 15.3852 $ 244,593.91 05/01/24 144,444 * $ 12.6860 $ 1,832,416.58 05/01/24 94,444 $ 12.5387 $ 1,184,204.98 05/01/24 94,444 $ 12.5332 $ 1,183,685.54 06/04/24 119,049 $ 19.7298 $ 2,348,812.96 06/04/24 69,839 $ 20.1324 $ 1,406,026.68 06/04/24 90,992 * $ 19.7296 $ 1,795,235.76 06/04/24 53,452 * $ 20.1325 $ 1,076,122.39 06/20/24 18,314 * $ 22.3457 $ 409,239.15 06/20/24 26,741 * $ 23.3661 $ 624,832.88 06/20/24 700 * $

View Full Filing

View this SC 13D/A filing on SEC EDGAR